Mulmit

Altimmune, Inc.Altimmune, Inc.

ALT Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3141,000-94,489,000-88,093,000-1
2024-12-3120,000-103,172,000-95,059,000-1.34
2023-12-31426,000-95,929,000-88,447,000-1.66
2022-12-31-68,000-87,740,000-84,713,000-1.81
2021-12-314,410,000-96,914,000-97,090,000-2.35

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-13Durso Jerome BenedictPresident and CEO15,000
2026-07-31Roberts M ScotChief Scientific Officer875
2026-07-31WEAVER GREGORY LChief Financial Officer1,753
2026-05-01Lawver Teri L48,800
2026-05-01Pisano Wayne48,800
2026-05-01Schafer Klaus48,800
2026-05-01Hodges Philip48,800
2026-05-01Sohn Catherine A.48,800
2026-05-01Jorkasky Diane48,800
2026-05-01GILL JOHN48,800
2026-05-01SAYARE MITCHEL48,800
2026-04-06GILL JOHN9,200

8-K events

FiledItems
2026-08-12Results of operations · Financial statements and exhibits
2026-07-28Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-16Other events
2026-05-13Results of operations · Financial statements and exhibits
2026-04-24Entry into a material agreement · Financial statements and exhibits
2026-04-16Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-03-05Results of operations · Financial statements and exhibits
2026-02-03Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.